We are monitoring the impact of COVID-19 & Recession alarm on MEA Bleeding Disorders Treatment Market Get in touch with us for detailed analysis Know More
Share on

Middle East & Africa Bleeding Disorders Treatment Market Research Report - Segmented By Drug Class, Type & Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis, Size, Share, Growth, Trends, & Forecasts (2022 to 2027)

Published: January, 2022
ID: 3234
Pages: 129

MEA Bleeding Disorders Treatment Market Size & Growth (2022 to 2027):

As per the research report, the size of the Middle East and Africa Bleeding Disorders Treatment Market is valued at USD 1.26 billion in 2022 and is estimated to be growing at a CAGR of 5.26%, to reach USD 1.63 billion by 2027 during the forecast period 2022 to 2027.

The market is showcasing evident potential in the mentioned forecasting period. A bleeding disorder is a condition that affects the clotting (coagulation) system of the body. If not taken care of this condition properly, serious damage can happen to the body in case of any wound or cut due to excessive loss of blood from the body.

There are various types of Bleeding Disorders, but the most frequently seen cases are Hemophilia A, Hemophilia B, and von Willebrand Disease  (vWD). A bleeding disorder is generally diagnosed by any of these three methods: Platelet Aggregation Test, Complete Blood Count (CBC) and bleeding time. There are various treatment methods depending on the type of bleeding disorder and its severity. Treatments include Iron Supplementation pills, Blood transfusion, and other methods.

Because of the poor economy in many countries of Africa and war regions in Middle Eastern countries, a huge amount of population in these regions suffer from malnutrition. As a result, iron deficiency cases in these regions are frequent, which is the root cause of bleeding disorders. Also, the fact that most of the bleeding disorders are inherited and cannot be completely cured is also driving this market. On the other hand, factors such as high cost of treatment including medication and lack of skilled practitioners to cure these types of disorders are challenging this market.

This research report segmented and sub-segmented into the following categories:

  • By Drug Class: Fibrin Sealant, Desmopressin, Antibrinolytics, Recombinant Coagulation Factor Concentrates and Plasma Derived Coagulation Factor Concentrates
  • By Type:  vWD, Hemophilia A, Hemophilia B
  • By Country:  KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA

The recombinant coagulation factor concentrates segment is expected to grow the fastest in the mentioned forecast period. This is because of the increased R&D in this market and the increasing focus of pharmaceutical companies on recombinant products.

The Middle East & African Region has the lowest growth rate and market share among all the regions but the opportunities for new companies are very high because of very few competitors present in this market.

The leading companies leading in the MEA Bleeding Disorders Treatment Market profiled in the report are  CSL Behring, Pfizer Inc., Novo Nordisk, Bayer AG, Biogen Inc., Shire Plc., Medline Plus, Janssen Middle East & Africa Services, LLC and Grifos SA.

1.Introduction          

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods  

                1.4 General Study Assumptions                

2. Research Methodology                   

                2.1 Introduction       

                2.2 Research Phases                      

        2.2.1 Secondary Research           

        2.2.2 Primary Research 

        2.2.3 Econometric Modelling      

        2.2.4 Expert Validation  

                2.3 Analysis Design 

                2.4 Study Timeline  

3. Overview               

                3.1 Executive Summary                

                3.2 Key Inferences 

                3.3 Epidemology      

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)            

                4.1 Market Drivers  

                4.2 Market Restraints                    

                4.3 Key Challenges 

                4.4 Current Opportunities in the Market      

5. Market Segmentation                      

                5.1 Drug Class                   

        5.1.1 Introduction           

        5.1.2 Fibrin Sealant         

        5.1.3 Desmopressin       

        5.1.4 Antibrinolytics       

        5.1.5 Recombinant Coagulation Factor Concentrates      

        5.1.6 Plasma Derived Coagulation Factor Concentrates  

        5.1.7  Y-o-Y Growth Analysis, By Drug Class          

        5.1.8  Market Attractiveness Analysis, By Drug Class        

        5.1.9  Market Share Analysis, By Drug Class         

                5.2 Type      

        5.2.1 Introduction           

        5.2.2 vWD           

        5.2.3 Hemophilia A         

        5.2.4 Hemophilia B          

        5.2.5 Y-o-Y Growth Analysis, By Type     

        5.2.6 Market Attractiveness Analysis, By Type   

        5.2.7 Market Share Analysis, By Type     

6. Geographical Analysis                      

                6.1 Introduction       

        6.1.1 Regional Trends    

        6.1.2 Impact Analysis     

        6.1.3 Y-o-Y Growth Analysis        

                        6.1.3.1 By Geographical Area

                        6.1.3.2 By Drug Class

                        6.1.3.3 By Type

        6.1.4  Market Attractiveness Analysis     

                        6.1.4.1 By Geographical Area

                        6.1.4.2 By Drug Class

                        6.1.4.3 By Type

        6.1.5  Market Share Analysis      

                        6.1.5.1 By Geographical Area

                        6.1.5.2 By Drug Class

                        6.1.5.3 By Type

                6.2 Middle-East        

                6.3 Africa    

7.Strategic Analysis                

                7.1 PESTLE analysis 

        7.1.1 Political     

        7.1.2 Economic 

        7.1.3 Social         

        7.1.4 Technological         

        7.1.5 Legal          

        7.1.6 Environmental       

                7.2 Porter’s Five analysis      

        7.2.1 Bargaining Power of Suppliers        

        7.2.2 Bargaining Power of Consumers    

        7.2.3 Threat of New Entrants     

        7.2.4 Threat of Substitute Products and Services              

        7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                 

                8.1 CSL Behring                

        8.1.1 Overview 

        8.1.2 Product Analysis   

        8.1.3 Financial analysis  

        8.1.4 Recent Developments       

        8.1.5 SWOT analysis       

        8.1.6 Analyst View          

                8.2 Pfizer Inc.                    

                8.3 Novo Nordisk    

                8.4 Bayer AG                     

                8.5 Biogen Inc.                  

                8.6 Shire Plc.                      

                8.7 LLC                 

                8.8 Medline Plus      

                8.9 Janssen Global Services

                8.10 Grifos SA                   

9.Competitive Landscape                    

                9.1 Market share analysis    

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures 

                9.4 New Product Launches 

10.Market Outlook and Investment Opportunities                  

Appendix                   

                a) List of Tables                

                b) List of Figures      

  1. Middle East & Africa Bleeding Disorders Treatment Market By Drug Class, From 2022 - 2027 ( USD Billion )
  2. Middle East & Africa Fibrin Sealant Market By Region, From 2022 - 2027 ( USD Billion )
  3. Middle East & Africa Desmopressin Market By Region, From 2022 - 2027 ( USD Billion )
  4. Middle East & Africa Antibrinolytics Market By Region, From 2022 - 2027 ( USD Billion )
  5. Middle East & Africa Recombinant Coagulation Factor Concentrates Market By Region, From 2022 - 2027 ( USD Billion )
  6. Middle East & Africa Plasma Derived Coagulation Factor Concentrates Market By Region, From 2022 - 2027 ( USD Billion )
  7. Middle East & Africa Bleeding Disorders Treatment Market By Type, From 2022 - 2027 ( USD Billion )
  8. Middle East & Africa vWD Market By Region, From 2022 - 2027 ( USD Billion )
  9. Middle East & Africa Hemophilia A Market By Region, From 2022 - 2027 ( USD Billion )
  10. Middle East & Africa Hemophilia B Market By Region, From 2022 - 2027 ( USD Billion )
  11. Middle East Bleeding Disorders Treatment Market By Drug Class, From 2022 - 2027 ( USD Billion )
  12. Middle East Bleeding Disorders Treatment Market By Type, From 2022 - 2027 ( USD Billion )
  13. Africa Bleeding Disorders Treatment Market By Drug Class, From 2022 - 2027 ( USD Billion )
  14. Africa Bleeding Disorders Treatment Market By Type, From 2022 - 2027 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

2875


pdf excel
$

3220


pdf excel powerbi
$

4600


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2875

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample